Sleep Chatbot Intervention for Emerging Black/African American Adults
Key facts
- Who runs it
- University of Delaware
- Where
- Newark, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 26 people enrolled
- Started
- 4 Sept 2023
- Ended
- 5 Feb 2025
- Type of study
- Interventional
- Treatments tested
- sleep chatbot
- Record updated
- 31 July 2026
Who can take part
- Age
- 18 years to 25 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- male or female ages 18-25 years old
- self-identified as Black/African Americans (BAA),
- poor sleep [Insomnia severity index (ISI) >10]
- having at least one of the cardiometabolic risk factors on the Life's Essential 8 checklist for cardiovascular health, as defined by the American Heart Association, including health factors confirmed by fasting blood testing during the first lab visit (fasting blood glucose ≥110mg/dL, high-density lipoprotein (good cholesterol) ≤ 40 mg/dL for males and ≤ 50 mg/dL for females, triglycerides ≥150mg/dL, total cholesterol ≥200 mg/dL, blood pressure ≥130/85mmHg, waist circumference≥40 inches for males, ≥35 inches for females) or healthy behaviors such as short sleep (<7 hours), smoking or inactive (<150 minutes/week of moderate aerobic activity such as gardening, social dancing, or < 75 minutes/week of vigorous aerobic activity such as running, swimming laps, jumping rope), and (e) own a smartphone (iPhone or Android)
- own a smartphone (iPhone or Android)
Who cannot take part
- regular use of medications with substantial impact on sleep and cardio-metabolic markers
- self-report medical conditions [i.e., major depressive disorder [Patient Health Questionnaire-9 (PHQ-9) ≥15)
- alcohol abuse (Alcohol Use Disorders Identification Test--short form score ≥7 for males and ≥5 for females)
- diagnosed obstructive apnea] that may affect sleep
- shift worker
- smoker
- self-report pregnancy/lactation
Where in United States
- University of DelawareNewark, United States
About the trial
What the trial wants to find out
Unhealthy sleep and cardiometabolic risk are two major public health concerns in emerging Black/African American (BAA) adults. Evidence-based sleep interventions such as cognitive-behavioral therapy for insomnia (CBT-I) are available but not aligned with the needs of this at-risk group. Innovative work on the development of an artificial intelligence sleep chatbot using CBT-I guidelines will provide scalable and efficient sleep interventions for emerging BAA adults.
The group in the trial
- sleep chatbot interventionTreatment being tested
Using CBT-I principles, participants will receive a four-week intervention delivered through a chatbot. The self-administered intervention is comprised of personalized behavioral prescriptions based on stimulus control principles and sleep schedule modification goals using sleep efficiency (SE) criteria. Participants are allowed to self-adjust expectations and make realistic decisions on sleep schedules. Other CBT-I components will be used as on-demand content. The chatbot will facilitate sleep goal setting with the participant, communicate weekly behavioral prescription and CBT-I educational modules, collect sleep diary and provide adaptive feedback and reactive services (e.g. Q\&A conversations) 24/7.
Treatment: sleep chatbot
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Artificial Intelligence Sleep Chatbot in Emerging Black/African American Adults With Cardiometabolic Risk Factors: a Feasibility Study
- Record updated
- 31 July 2026